THIRD GENERATION CEPHALOSPORINS

Course overview

THIRD-GENERATION CEPHALOSPORINS ARE MEDICATIONS USED IN THE MANAGEMENT AND TREATMENT OF GRAM-NEGATIVE AND GRAM-POSITIVE ORGANISMS. THEY ARE ENCOMPASSED AMONG THE BETA-LACTAM CLASS OF DRUGS. THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR THIRD-GENERATION CEPHALOSPORINS AS A VALUABLE AGENT IN THE MANAGEMENT OF GRAM-NEGATIVE MENINGITIS, LYME DISEASE, PSEUDOMONAS PNEUMONIA, GRAM-NEGATIVE SEPSIS, STREPTOCOCCAL ENDOCARDITIS, MELIOIDOSIS, PENICILLINASE-PRODUCING NEISSERIA GONORRHEA, CHANCROID, AND GRAM-NEGATIVE OSTEOMYELITIS. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL HEALTHCARE TEAM IN THE TREATMENT OF PATIENTS WITH GRAM-POSITIVE AND GRAM-NEGATIVE INFECTIONS AND RELATED CONDITIONS.